1-(1-hydroxy-[2]naphthyl)-3-(4-methoxy-phenyl)-propane-1,3-dione | 370583-68-9

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: 1-(1-hydroxy-[2]naphthyl)-3-(4-methoxy-phenyl)-propane-1,3-dione
• 英文别名: 1-(1-Hydroxy-[2]naphthyl)-3-(4-methoxy-phenyl)-propan-1,3-dion；1-(1-Hydroxynaphthalen-2-yl)-3-(4-methoxyphenyl)propane-1,3-dione
• CAS: 370583-68-9
• 化学式: C₂₀H₁₆O₄
• 分子量: 320.345
• InChiKey: JRHSIUOBVWRNOS-UHFFFAOYSA-N

物化性质

• 熔点：
  135-137 °C
• 沸点：
  558.9±35.0 °C(Predicted)
• 密度：
  1.264±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-(1-hydroxy-[2]naphthyl)-3-(4-methoxy-phenyl)-propane-1,3-dione 在 硫酸 、 氢溴酸 、 溶剂黄146 作用下， 以 乙醇 、 水 为溶剂， 反应 2.5h， 生成 4'-hydroxy-α-naphthoflavone
  参考文献：
  名称：

  Design and synthesis of selective CYP1B1 inhibitor via dearomatization of α-naphthoflavone

  摘要：

  Selective cytochrome P450 (CYP) 1B1 inhibition has potential as an anticancer strategy that is unrepresented in the current clinical arena. For development of a selective inhibitor, we focused on the complexity caused by sp(3)-hybridized carbons and synthesized a series of benzo[h] chromone derivatives linked to a non-aromatic B-ring using alpha-naphthoflavone (ANF) as the lead compound. Ring structure comparison suggested compound 37 as a suitable cyclohexyl-core with improved solubility. Structural evolution of 37 produced the azide-containing cis-49a, which had good properties in three important respects: (1) selectivity for CYP1B1 over CYP1A1 and CYP1A2 (120-times and 150-times, respectively), (2) greater inhibitory potency of > 2 times that of ANF, and (3) improved solubility. The corresponding aromatic B-ring compound 59a showed low selectivity and poor solubility. To elucidate the binding mode, we performed X-ray crystal structure analysis, which revealed the interaction mode and explained the subtype selectivity of cis-49a.

  DOI：

  10.1016/j.bmc.2018.11.045
• 作为产物：
  描述：

  2-乙酰基-1-萘酚 在 吡啶 、 potassium hydroxide 作用下， 以 吡啶 为溶剂， 反应 1.25h， 生成 1-(1-hydroxy-[2]naphthyl)-3-(4-methoxy-phenyl)-propane-1,3-dione
  参考文献：
  名称：

  Benzoflavone derivatives as potent antihyperuricemic agents

  摘要：

  苯并黄酮衍生物经过合理设计、合成并针对黄嘌呤氧化酶进行评估，以检测它们的抗高尿酸作用，使用体外和体内方法。

  DOI：

  10.1039/c8md00512e

文献信息

• Benzoflavone activators of the cystic fibrosis transmembrane conductance regulator: towards a pharmacophore model for the nucleotide-binding domain
  作者：Mark F Springsteel、Luis J.V Galietta、Tonghui Ma、Kolbot By、Gideon O Berger、Hong Yang、Christopher W Dicus、Wonken Choung、Chao Quan、Anang A Shelat、R.Kiplin Guy、A.S Verkman、Mark J Kurth、Michael H Nantz

  DOI：10.1016/s0968-0896(03)00435-8

  日期：2003.9

  using cell-based assays, of a series of benzoflavone analogues to examine structure-activity relationships and to identify compounds having greater potency for activation of both wild type CFTR and a mutant CFTR (G551D-CFTR) that causes cystic fibrosis in some human subjects. Using UCCF-029 as a structural guide, a panel of 77 flavonoid analogues was prepared. Analysis of the panel in FRT cells indicated

  我们以前对黄酮类化合物和相关杂环的筛选具有激活囊性纤维化跨膜电导调节剂（CFTR）氯化物通道的能力，这表明UCCF-029是一种7,8-苯并黄酮，是一种有效的活化剂。在本研究中，我们描述了使用基于细胞的分析方法对一系列苯并黄酮类似物进行合成和评估，以检查其结构活性关系，并鉴定出对野生型CFTR和突变型CFTR（G551D -CFTR）在某些人类受试者中引起囊性纤维化。使用UCCF-029作为结构指导，制备了77种类黄酮类似物。对FRT细胞中面板的分析表明，黄酮A环在7,8位的苯环显着提高了化合物活性和几种类黄酮的效力。在3或4位上引入B环吡啶基氮也可提高CFTR活性，但这种结构修饰的影响不如苯甲环化均匀。最有效的新类似物UCCF-339以1.7 microM的K（d）激活了野生型CFTR，它比以前最有效的CFTR类黄酮活化剂芹菜素具有更高的活性。苯并黄酮类化合物中的几种化合物也可以活化G5
• Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors
  作者：Jinyun Dong、Zengtao Wang、Jiahua Cui、Qingqing Meng、Shaoshun Li

  DOI：10.1016/j.ejmech.2019.111938

  日期：2020.2

  CYP1B1 inhibitory capacity. Among these derivatives, compounds 9e and 9j were identified as the most potent two selective CYP1B1 inhibitors with IC50 values of 0.49 and 0.52 nM, respectively, which were 10-fold more potent than the lead compound ANF. In addition, molecular docking and a reasonable 3D-QSAR (three-dimensional quantitative structure-activity relationship) study were performed to provide a

  细胞色素P450 1B1（CYP1B1）被公认为是预防癌症和逆转耐药性的重要靶标。为了获得有效和选择性的CYP1B1抑制剂，合成了一系列41种α-萘黄酮（ANF）衍生物，进行了表征，并评估了其对CYP1B1，CYP1A1和CYP1A2的抑制活性。封闭结构对CYP1B1抑制作用的活性关系研究表明，修饰ANF的C环会降低CYP1B1的抑制能力，而在B环的不同位置引入取代基会产生类似的变化CYP1B1的抑制能力。在这些衍生物中，化合物9e和9j被确定为最有效的两种选择性CYP1B1抑制剂，IC50值分别为0.49和0.52 nM，其效力比先导化合物ANF强10倍。此外，进行了分子对接和合理的3D-QSAR（三维定量结构-活性关系）研究，以更好地理解影响CYP1B1抑制活性的关键结构特征。这项研究中获得的结果将为将来开发选择性，有效，低毒和水溶性CYP1B1抑制剂奠定基础。
• Benzoflavones as cholesterol esterase inhibitors: Synthesis, biological evaluation and docking studies
  作者：Harbinder Singh、Jatinder Vir Singh、Manish K. Gupta、Palwinder Singh、Sahil Sharma、Kunal Nepali、Preet Mohinder S. Bedi

  DOI：10.1016/j.bmcl.2017.01.020

  日期：2017.2

  A library of forty 7,8-benzoflavone derivatives was synthesized and evaluated for their inhibitory potential against cholesterol esterase (CEase). Among all the synthesized compounds seven benzoflavone derivatives (A-7, A-8, A-10, A-11, A-12, A-13, A-15) exhibited significant inhibition against CEase in in vitro enzymatic assay. Compound A-12 showed the most promising activity with IC50 value of 0.78 nM against cholesterol esterase. Enzyme kinetic studies carried out for A-12, revealed its mixed-type inhibition approach. Molecular protein ligand docking studies were also performed to figure out the key binding interactions of A-12 with the amino acid residues of the enzyme's active site. The A-12 fits well at the catalytic site and is stabilized by hydrophobic interactions. It completely blocks the catalytic assembly of CEase and prevents it to participate in ester hydrolysis mechanism. The favorable binding conformation of A-12 suggests its prevailing role as CEase inhibitor. (C) 2017 Elsevier Ltd. All rights reserved.
• Dunne et al., Journal of the Chemical Society, 1950, p. 1252,1257
  作者：Dunne et al.

  DOI：——

  日期：——
• Design and synthesis of selective CYP1B1 inhibitor via dearomatization of α-naphthoflavone
  作者：Makoto Kubo、Keiko Yamamoto、Toshimasa Itoh

  DOI：10.1016/j.bmc.2018.11.045

  日期：2019.1

  Selective cytochrome P450 (CYP) 1B1 inhibition has potential as an anticancer strategy that is unrepresented in the current clinical arena. For development of a selective inhibitor, we focused on the complexity caused by sp(3)-hybridized carbons and synthesized a series of benzo[h] chromone derivatives linked to a non-aromatic B-ring using alpha-naphthoflavone (ANF) as the lead compound. Ring structure comparison suggested compound 37 as a suitable cyclohexyl-core with improved solubility. Structural evolution of 37 produced the azide-containing cis-49a, which had good properties in three important respects: (1) selectivity for CYP1B1 over CYP1A1 and CYP1A2 (120-times and 150-times, respectively), (2) greater inhibitory potency of > 2 times that of ANF, and (3) improved solubility. The corresponding aromatic B-ring compound 59a showed low selectivity and poor solubility. To elucidate the binding mode, we performed X-ray crystal structure analysis, which revealed the interaction mode and explained the subtype selectivity of cis-49a.